Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PLG | P00747 | 1/20 | 0.31 |
| ▸ | PLAU | P00749 | 1/20 | 0.31 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29506779 | 1.00 | HSP90AA1 (0.37) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL12811732 | 0.85 | HSP90AA1 (0.38) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL29402889 | 0.84 | CYP1A2 (0.39) | ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL838416 | 0.84 | CYP1A2 (0.39) | ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2477502 | 0.83 | HSP90AA1 (0.37) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL4047614 | 0.83 | HSP90AA1 (0.37) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL29793307 | 0.83 | HSP90AA1 (0.37) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL29561615 | 0.83 | HSP90AA1 (0.37) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL4569875 | 0.82 | HSP90AA1 (0.37) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL4569895 | 0.82 | HSP90AA1 (0.37) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117777071-A | Preparation method of methyl arginine | 南京药坦生物科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20260137821-A1 | PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF | C-BIOMEX CO., LTD. (KR) | 2026-05-21 | — | — | US | disclosed |
| US-20260117257-A1 | MRNA Delivery System Targeting DC Cells and Preparation Method Therefor | WINLEIN TIANJIN BIOTECHNOLOGY CO LTD (CN) | 2026-04-30 | — | — | US | disclosed |
| EP-4608452-A2 | PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | Eisai R&D Management Co., Ltd. (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-20250136545-A1 | NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY | GLUCOX BIOTECH AB (SE) | 2025-05-01 | — | — | US | disclosed |
| WO-2025023747-A1 | PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF | (주)씨바이오멕스 | 2025-01-30 | — | — | WO | disclosed |
| US-12202790-B2 | Sulfonamide derivatives having selective Nox inhibiting activity | GLUCOX BIOTECH AB (SE) | 2025-01-21 | — | — | US | disclosed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| WO-2024208277-A1 | CALCITONIN ANALOGUE, AND DERIVATIVE THEREOF AND USE THEREOF | 杭州先为达生物科技股份有限公司 | 2024-10-10 | — | — | WO | disclosed |
| US-20240325307-A1 | HIGH DENSITY PEPTIDE POLYMERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-03 | — | — | US | disclosed |
| WO-2019215291-A1 | NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY | GLUCOX BIOTECH AB (SE) | 2019-11-14 | — | — | WO | disclosed |
| US-20190135776-A1 | THERAPEUTICS TARGETING TRUNCATED ADENOMATOUS POLYPOSIS COLI (APC) PROTEINS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2019-05-09 | — | — | US | disclosed |
| EP-3398957-A1 | METHOD FOR SYNTHESIZING ETELCALCETIDE | Hybio Pharmaceutical Co., Ltd (CN) | 2018-11-07 | — | — | EP | disclosed |
| US-20180042843-A1 | HIGH DENSITY PEPTIDE POLYMERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-02-15 | — | — | US | disclosed |
| US-9856233-B2 | Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-01-02 | — | — | US | disclosed |
| WO-2017100154-A1 | INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES | PURDUE RESEARCH FOUNDATION (US) | 2017-06-15 | — | — | WO | disclosed |
| EP-3044218-A2 | THERAPEUTICS TARGETING TRUNCATED ADENOMATOUS POLYPOSIS COLI (APC) PROTEINS | Board Of Regents Of the University Of Texas System (US) | 2016-07-20 | — | — | EP | disclosed |
| EP-2299821-B1 | TRICYCLIC COMPOUNDS | ABBVIE INC (US) | 2015-11-04 | — | — | EP | disclosed |
| US-20150232444-A1 | THERAPEUTICS TARGETING TRUNCATED ADENOMATOUS POLYPOSIS COLI (APC) PROTEINS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2015-08-20 | — | — | US | disclosed |
| CN-100453537-C | Process for preparing amino-acid with dual protection | YIFURUI INDUSTRY CO LTD (CN) | 2009-01-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232444-A1 | THERAPEUTICS TARGETING TRUNCATED ADENOMATOUS POLYPOSIS COLI (APC) PROTEINS | APC, VHL, TP53 | HSP90AA1 907/4885HSP90AB1 719/4885ALDH1A1 4595/4885 |
| US-12202790-B2 | Sulfonamide derivatives having selective Nox inhibiting activity | NOX4, NOX1, NOX5 | HSP90AA1 1069/4885HSP90AB1 691/4885ALDH1A1 493/4885 |
| US-20190135776-A1 | THERAPEUTICS TARGETING TRUNCATED ADENOMATOUS POLYPOSIS COLI (APC) PROTEINS | APC, VHL, TP53 | HSP90AA1 907/4885HSP90AB1 719/4885ALDH1A1 4595/4885 |
| US-20250136545-A1 | NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY | NOX4, NOX1, NOX5 | HSP90AA1 1264/4885HSP90AB1 847/4885ALDH1A1 473/4885 |
| US-20180042843-A1 | HIGH DENSITY PEPTIDE POLYMERS | ERMP1, PARL, PRAP1 | HSP90AA1 2448/4885HSP90AB1 1336/4885ALDH1A1 4678/4885 |
| US-20260117257-A1 | MRNA Delivery System Targeting DC Cells and Preparation Method Therefor | RNMT, RNGTT, CD4 | HSP90AA1 1360/4885HSP90AB1 1476/4885ALDH1A1 3800/4885 |
| US-20260137821-A1 | PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF | CA5A, CA1, CA9 | HSP90AA1 2329/4885HSP90AB1 1750/4885ALDH1A1 949/4885 |
| US-20240325307-A1 | HIGH DENSITY PEPTIDE POLYMERS | IAPP, LCP1, LNPEP | HSP90AA1 453/4885HSP90AB1 706/4885ALDH1A1 4773/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | HSP90AA1 906/4885HSP90AB1 1464/4885ALDH1A1 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.